Zelira Therapeutics Ltd (ASX:ZLD) founder and chairman Osagie Imasogie and deputy chairman Harry Karelis speaks to Proactive on the recent acquisition of Ilera Therapeutics LLC.
Following overwhelming shareholder support, the merger will create a global medicinal cannabis company called Zelira Therapeutics Limited.
The merger will bring together a portfolio of revenue-generating medicines and products undergoing clinical development that are expected to enter the market from 2020.
Price: 0.056 AUD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Zelira Therapeutics Ltd. named herein, including the promotion by the Company of Zelira Therapeutics Ltd. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE
Zelda Therapeutics Ltd (ASX:ZLD, OTCBB:ZLDAF) managing director Dr Richard Hopkins speaks to Proactive Investors about the medical cannabis researcher's binding heads of agreement (HoA) with US-based medicinal cannabis company Ilera Healthcare LLC. The deal complements a number of...
Prev article
